Review



cd8  (Cedarlane)


Bioz Verified Symbol Cedarlane is a verified supplier
Bioz Manufacturer Symbol Cedarlane manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cedarlane cd8
    Cd8, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 21 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8a+igg2a+antibody/Anti-Mouse+CD8a+(Ly+2)+APC+(Clone+CT-CD8a)+(rat+IgG2a)/pm40329465-50-13-41
    Average 93 stars, based on 21 article reviews
    cd8 - by Bioz Stars, 2026-11
    93/100 stars

    Images

    Related Articles

    Injection:

    Article Title: Papilloma-pseudovirus eradicates intestinal tumours and triples the lifespan of Apc Min/+ mice
    Article Snippet: .. For CD8 + T-cell depletion, mice were i.p. injected with 250 μg of anti-CD8a IgG2a antibody (from Cedarlane) at 2 days and 1 day before every pseudovirus immunization. ..

    Article Title: Inflammasome activators and methods of use to treat tumors
    Article Snippet: .. In vivo depletion of CD8+ T cells and serum transfer: For CD8+ T cell depletion, mice were intraperitoneally (i.p.) injected with 250 μg of anti-CD8a IgG2a antibody (from Cedarlane) at 2- and 1-day before every pseudovirus immunization. ..

    In Vivo:

    Article Title: Inflammasome activators and methods of use to treat tumors
    Article Snippet: .. In vivo depletion of CD8+ T cells and serum transfer: For CD8+ T cell depletion, mice were intraperitoneally (i.p.) injected with 250 μg of anti-CD8a IgG2a antibody (from Cedarlane) at 2- and 1-day before every pseudovirus immunization. ..



    Similar Products

    86
    Tokyo Chemical Industry anti cd8a igg2a mab
    Anti Cd8a Igg2a Mab, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8a+igg2a+antibody/anti+bgr23+gb3+igg2b+mab+mouse/us12521429-263-10-16
    Average 86 stars, based on 1 article reviews
    anti cd8a igg2a mab - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    93
    Cedarlane cd8
    Cd8, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8a+igg2a+antibody/Anti-Mouse+CD8a+(Ly+2)+APC+(Clone+CT-CD8a)+(rat+IgG2a)/pm40329465-50-13-41
    Average 93 stars, based on 1 article reviews
    cd8 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Cedarlane anti cd8a antibody
    ( A ) Tumor growth curves (means ± SE) of vehicle, anti–PD-L1 antibody alone (300 μg per body, once weekly), ceralasertib alone (50 mg/kg, 5 of 7 days, once a day.), and ceralasertib plus anti–PD-L1 antibody groups in B6129F1 mice injected with RPP cells ( n = 4 in vehicle and anti–PD-L1 antibody group, n = 6 in the other groups). ( B to E ) RPP tumors were harvested on day 22 for immune profiling by flow cytometry ( n = 4 in vehicle and anti–PD-L1 antibody group, n = 6 in ceralasertib, n = 5 in ceralasertib plus anti–PD-L1 antibody group). Flow cytometry analysis of (B) CD45 + CD3 + T cells, (C) CD45 + CD3 + <t>CD8</t> + T cells, (D) CD45 + CD3 + CD8 + ICOS + T cells, (E) effector memory CD8 + T cells: CD45 + CD3 + CD8 + CD44 hi CD62L lo . Percentages in (B), (C), and (E) were calculated relative to CD45 + cells, and percentages in (D) were calculated relative to CD45 + CD8 + cells. ( F ) CD8 immunohistochemistry was performed on tumor sections resected on day 22. Scale bar, 50 μm. ( G ) Tumor growth curves (means ± SE) of vehicle, anti–PD-L1 antibody alone, ceralasertib alone, and ceralasertib plus anti–PD-L1 antibody [same dose as (A)] groups in B6FVBF1/J mice injected with RPM cells ( n = 6 per group). ( H to K ) RPM tumors were harvested at day 18 for immune profiling by flow cytometry ( n = 5 in anti–PD-L1 group and n = 6 in the other groups). Flow cytometry analysis of (H) CD45 + CD3 + T cells, (I) CD45 + CD3 + CD8 + T cells, (J) CD45 + CD3 + CD8 + ICOS + T cells, and (K) effector memory CD8 + T cells: CD45 + CD3 + CD8 + CD44 hi CD62L lo . Percentages were the ratio to CD45 + cells. ( L ) CD8 immunohistochemistry of tumors resected on day 18. Scale bar, 50 μm. Cerala, ceralasertib. P values were calculated by one-way analysis of variance (ANOVA). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, and by Student’s t test for comparing ceralasertib alone and ceralasertib plus anti–PD-L1 antibody (A). ab, antibody. ns, not significant.
    Anti Cd8a Antibody, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8a+igg2a+antibody/Anti-Mouse+CD8a+(Ly+2)+APC+(Clone+CT-CD8a)+(rat+IgG2a)/pmc11430494-347-12-14
    Average 93 stars, based on 1 article reviews
    anti cd8a antibody - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Cedarlane anti cd8 cedarlane
    ( A ) Tumor growth curves (means ± SE) of vehicle, anti–PD-L1 antibody alone (300 μg per body, once weekly), ceralasertib alone (50 mg/kg, 5 of 7 days, once a day.), and ceralasertib plus anti–PD-L1 antibody groups in B6129F1 mice injected with RPP cells ( n = 4 in vehicle and anti–PD-L1 antibody group, n = 6 in the other groups). ( B to E ) RPP tumors were harvested on day 22 for immune profiling by flow cytometry ( n = 4 in vehicle and anti–PD-L1 antibody group, n = 6 in ceralasertib, n = 5 in ceralasertib plus anti–PD-L1 antibody group). Flow cytometry analysis of (B) CD45 + CD3 + T cells, (C) CD45 + CD3 + <t>CD8</t> + T cells, (D) CD45 + CD3 + CD8 + ICOS + T cells, (E) effector memory CD8 + T cells: CD45 + CD3 + CD8 + CD44 hi CD62L lo . Percentages in (B), (C), and (E) were calculated relative to CD45 + cells, and percentages in (D) were calculated relative to CD45 + CD8 + cells. ( F ) CD8 immunohistochemistry was performed on tumor sections resected on day 22. Scale bar, 50 μm. ( G ) Tumor growth curves (means ± SE) of vehicle, anti–PD-L1 antibody alone, ceralasertib alone, and ceralasertib plus anti–PD-L1 antibody [same dose as (A)] groups in B6FVBF1/J mice injected with RPM cells ( n = 6 per group). ( H to K ) RPM tumors were harvested at day 18 for immune profiling by flow cytometry ( n = 5 in anti–PD-L1 group and n = 6 in the other groups). Flow cytometry analysis of (H) CD45 + CD3 + T cells, (I) CD45 + CD3 + CD8 + T cells, (J) CD45 + CD3 + CD8 + ICOS + T cells, and (K) effector memory CD8 + T cells: CD45 + CD3 + CD8 + CD44 hi CD62L lo . Percentages were the ratio to CD45 + cells. ( L ) CD8 immunohistochemistry of tumors resected on day 18. Scale bar, 50 μm. Cerala, ceralasertib. P values were calculated by one-way analysis of variance (ANOVA). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, and by Student’s t test for comparing ceralasertib alone and ceralasertib plus anti–PD-L1 antibody (A). ab, antibody. ns, not significant.
    Anti Cd8 Cedarlane, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8a+igg2a+antibody/pm39248192-79-14-15
    Average 93 stars, based on 1 article reviews
    anti cd8 cedarlane - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Cedarlane cd8a
    ( A ) Tumor growth curves (means ± SE) of vehicle, anti–PD-L1 antibody alone (300 μg per body, once weekly), ceralasertib alone (50 mg/kg, 5 of 7 days, once a day.), and ceralasertib plus anti–PD-L1 antibody groups in B6129F1 mice injected with RPP cells ( n = 4 in vehicle and anti–PD-L1 antibody group, n = 6 in the other groups). ( B to E ) RPP tumors were harvested on day 22 for immune profiling by flow cytometry ( n = 4 in vehicle and anti–PD-L1 antibody group, n = 6 in ceralasertib, n = 5 in ceralasertib plus anti–PD-L1 antibody group). Flow cytometry analysis of (B) CD45 + CD3 + T cells, (C) CD45 + CD3 + <t>CD8</t> + T cells, (D) CD45 + CD3 + CD8 + ICOS + T cells, (E) effector memory CD8 + T cells: CD45 + CD3 + CD8 + CD44 hi CD62L lo . Percentages in (B), (C), and (E) were calculated relative to CD45 + cells, and percentages in (D) were calculated relative to CD45 + CD8 + cells. ( F ) CD8 immunohistochemistry was performed on tumor sections resected on day 22. Scale bar, 50 μm. ( G ) Tumor growth curves (means ± SE) of vehicle, anti–PD-L1 antibody alone, ceralasertib alone, and ceralasertib plus anti–PD-L1 antibody [same dose as (A)] groups in B6FVBF1/J mice injected with RPM cells ( n = 6 per group). ( H to K ) RPM tumors were harvested at day 18 for immune profiling by flow cytometry ( n = 5 in anti–PD-L1 group and n = 6 in the other groups). Flow cytometry analysis of (H) CD45 + CD3 + T cells, (I) CD45 + CD3 + CD8 + T cells, (J) CD45 + CD3 + CD8 + ICOS + T cells, and (K) effector memory CD8 + T cells: CD45 + CD3 + CD8 + CD44 hi CD62L lo . Percentages were the ratio to CD45 + cells. ( L ) CD8 immunohistochemistry of tumors resected on day 18. Scale bar, 50 μm. Cerala, ceralasertib. P values were calculated by one-way analysis of variance (ANOVA). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, and by Student’s t test for comparing ceralasertib alone and ceralasertib plus anti–PD-L1 antibody (A). ab, antibody. ns, not significant.
    Cd8a, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8a+igg2a+antibody/Anti-Mouse+CD8a+(Ly+2)+APC+(Clone+CT-CD8a)+(rat+IgG2a)/pm36868467-61-21-43
    Average 93 stars, based on 1 article reviews
    cd8a - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec rat anti igg2a percp miltenyi biotec
    ( A ) Tumor growth curves (means ± SE) of vehicle, anti–PD-L1 antibody alone (300 μg per body, once weekly), ceralasertib alone (50 mg/kg, 5 of 7 days, once a day.), and ceralasertib plus anti–PD-L1 antibody groups in B6129F1 mice injected with RPP cells ( n = 4 in vehicle and anti–PD-L1 antibody group, n = 6 in the other groups). ( B to E ) RPP tumors were harvested on day 22 for immune profiling by flow cytometry ( n = 4 in vehicle and anti–PD-L1 antibody group, n = 6 in ceralasertib, n = 5 in ceralasertib plus anti–PD-L1 antibody group). Flow cytometry analysis of (B) CD45 + CD3 + T cells, (C) CD45 + CD3 + <t>CD8</t> + T cells, (D) CD45 + CD3 + CD8 + ICOS + T cells, (E) effector memory CD8 + T cells: CD45 + CD3 + CD8 + CD44 hi CD62L lo . Percentages in (B), (C), and (E) were calculated relative to CD45 + cells, and percentages in (D) were calculated relative to CD45 + CD8 + cells. ( F ) CD8 immunohistochemistry was performed on tumor sections resected on day 22. Scale bar, 50 μm. ( G ) Tumor growth curves (means ± SE) of vehicle, anti–PD-L1 antibody alone, ceralasertib alone, and ceralasertib plus anti–PD-L1 antibody [same dose as (A)] groups in B6FVBF1/J mice injected with RPM cells ( n = 6 per group). ( H to K ) RPM tumors were harvested at day 18 for immune profiling by flow cytometry ( n = 5 in anti–PD-L1 group and n = 6 in the other groups). Flow cytometry analysis of (H) CD45 + CD3 + T cells, (I) CD45 + CD3 + CD8 + T cells, (J) CD45 + CD3 + CD8 + ICOS + T cells, and (K) effector memory CD8 + T cells: CD45 + CD3 + CD8 + CD44 hi CD62L lo . Percentages were the ratio to CD45 + cells. ( L ) CD8 immunohistochemistry of tumors resected on day 18. Scale bar, 50 μm. Cerala, ceralasertib. P values were calculated by one-way analysis of variance (ANOVA). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, and by Student’s t test for comparing ceralasertib alone and ceralasertib plus anti–PD-L1 antibody (A). ab, antibody. ns, not significant.
    Rat Anti Igg2a Percp Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8a+igg2a+antibody/CD8a+Antibody%2C+anti-mouse%2C+REAfinity/pmc09763194__gutjnl___2021___326023supp001-6-40-43
    Average 94 stars, based on 1 article reviews
    rat anti igg2a percp miltenyi biotec - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    90
    Becton Dickinson apc-conjugated anti-mouse-cd8a (clone: 53-6.7, rat igg2a)
    FACS-Analysis of spleen DX5 + NKT cells revealed interstrain differences in several phenotypical markers between NK1.1 - Balb/c and NK1.1 + C57Bl/6 mice . In the NK1.1 + mice strain spleen DX5 + NKT cells expressed less CD4 but more <t>CD8</t> (A). Upon activation the TCR α/β down-regulation was confirmed. In addition to NK.1.1 more spleen DX5 + NKT cells in C57Bl/6 mice were positive for CD94 (B). Maturation marker CD62L was slightly higher expressed in freshly-isolated spleen DX5 + NKT cells in C57Bl/6 mice compared to Balb/c, whereas CD103 was less (C). Functional marker CD154 and CD178 were only little expressed in freshly-isolated spleen DX5 + NKT cells in both mice strains (D). Upon stimulation spleen DX5 + NKT cells in NK1.1 + C57Bl/6 mice displayed less up-regulation of CD154 compared to Balb/c. Results are given as mean + SEM. Experiments were repeated at least three times (* p < 0.05).
    Apc Conjugated Anti Mouse Cd8a (Clone: 53 6.7, Rat Igg2a), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8a+igg2a+antibody/anti+cd3/pmc03097004-171-35-82
    Average 90 stars, based on 1 article reviews
    apc-conjugated anti-mouse-cd8a (clone: 53-6.7, rat igg2a) - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson rat igg2a anti-murine cd8a (53–6.7
    C57BL/6 mice were infected with P. berghei ANKA and treated with vehicle, losartan or captopril by gavage. T cells were isolated at day 6 post infection, stained with fluorescent antibodies, and analyzed by flow cytometry. (A) Representative dot plots of CD4 + CD69 + and <t>CD8</t> + CD69 + T cells obtained from gated CD3 + cells. Percentage of CD4 + CD69 + T cells (B) and CD8 + CD69 + T cells (C). Parasitemia was determined by Giemsa-stained blood smears in vehicle- (solid line), losartan- (dotted line) or captopril- (dash line) treated mice (D). Mortality was checked daily in vehicle- (▪), losartan- (▴) or captopril- (▾) treated mice (E). Behavioral analysis was assessed as described in Materials and Methods (F). Evans blue dye extraction from the brain tissue to evaluate blood-brain barrier disruption (G). The results are expressed as means±SD. Statistically significant compared with values for *naive mice ( p <0.05) and #vehicle-treated mice infected with P. berghei ANKA ( p <0.05). Statistically significant compared with values for vehicle-treated infected mice at a day 5, b day 7 or day c 10 post-infection.
    Rat Igg2a Anti Murine Cd8a (53–6.7, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8a+igg2a+antibody/anti+cd3/pmc03639972-47-20-90
    Average 90 stars, based on 1 article reviews
    rat igg2a anti-murine cd8a (53–6.7 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson alexa 648 or fitc-conjugated anti-mouse-cd8a 53–6.7, rat igg2a
    Flow cytometry analysis of the spleen CD3 + DX5 + NKT, <t>CD8</t> + T, CD4 + CD62L high , and CD4 + CD62L low cells of Balb/c mice after separation by MACS and FACS sorting (a). Proliferation (b) and proliferation index (c) of CFSE-labeled CD4 + CD62L high cells after 48 h and 96 h of monoculture or coculture with CD8 + T cells or CD3 + DX5 + NKT. Results are given as mean + SEM. Experiments were repeated at least three times ( ∗ P < 0.05).
    Alexa 648 Or Fitc Conjugated Anti Mouse Cd8a 53–6.7, Rat Igg2a, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8a+igg2a+antibody/anti+cd3/pmc06186349-52-39-73
    Average 90 stars, based on 1 article reviews
    alexa 648 or fitc-conjugated anti-mouse-cd8a 53–6.7, rat igg2a - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson apc-h7-conjugated anti-mouse cd8a 53–6.7; isotype: rat (lou) igg2a, κ
    Flow cytometry analysis of the spleen CD3 + DX5 + NKT, <t>CD8</t> + T, CD4 + CD62L high , and CD4 + CD62L low cells of Balb/c mice after separation by MACS and FACS sorting (a). Proliferation (b) and proliferation index (c) of CFSE-labeled CD4 + CD62L high cells after 48 h and 96 h of monoculture or coculture with CD8 + T cells or CD3 + DX5 + NKT. Results are given as mean + SEM. Experiments were repeated at least three times ( ∗ P < 0.05).
    Apc H7 Conjugated Anti Mouse Cd8a 53–6.7; Isotype: Rat (Lou) Igg2a, κ, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8a+igg2a+antibody/anti+cd3/pmc03991673-54-0-52
    Average 90 stars, based on 1 article reviews
    apc-h7-conjugated anti-mouse cd8a 53–6.7; isotype: rat (lou) igg2a, κ - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Tumor growth curves (means ± SE) of vehicle, anti–PD-L1 antibody alone (300 μg per body, once weekly), ceralasertib alone (50 mg/kg, 5 of 7 days, once a day.), and ceralasertib plus anti–PD-L1 antibody groups in B6129F1 mice injected with RPP cells ( n = 4 in vehicle and anti–PD-L1 antibody group, n = 6 in the other groups). ( B to E ) RPP tumors were harvested on day 22 for immune profiling by flow cytometry ( n = 4 in vehicle and anti–PD-L1 antibody group, n = 6 in ceralasertib, n = 5 in ceralasertib plus anti–PD-L1 antibody group). Flow cytometry analysis of (B) CD45 + CD3 + T cells, (C) CD45 + CD3 + CD8 + T cells, (D) CD45 + CD3 + CD8 + ICOS + T cells, (E) effector memory CD8 + T cells: CD45 + CD3 + CD8 + CD44 hi CD62L lo . Percentages in (B), (C), and (E) were calculated relative to CD45 + cells, and percentages in (D) were calculated relative to CD45 + CD8 + cells. ( F ) CD8 immunohistochemistry was performed on tumor sections resected on day 22. Scale bar, 50 μm. ( G ) Tumor growth curves (means ± SE) of vehicle, anti–PD-L1 antibody alone, ceralasertib alone, and ceralasertib plus anti–PD-L1 antibody [same dose as (A)] groups in B6FVBF1/J mice injected with RPM cells ( n = 6 per group). ( H to K ) RPM tumors were harvested at day 18 for immune profiling by flow cytometry ( n = 5 in anti–PD-L1 group and n = 6 in the other groups). Flow cytometry analysis of (H) CD45 + CD3 + T cells, (I) CD45 + CD3 + CD8 + T cells, (J) CD45 + CD3 + CD8 + ICOS + T cells, and (K) effector memory CD8 + T cells: CD45 + CD3 + CD8 + CD44 hi CD62L lo . Percentages were the ratio to CD45 + cells. ( L ) CD8 immunohistochemistry of tumors resected on day 18. Scale bar, 50 μm. Cerala, ceralasertib. P values were calculated by one-way analysis of variance (ANOVA). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, and by Student’s t test for comparing ceralasertib alone and ceralasertib plus anti–PD-L1 antibody (A). ab, antibody. ns, not significant.

    Journal: Science Advances

    Article Title: ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer

    doi: 10.1126/sciadv.ado4618

    Figure Lengend Snippet: ( A ) Tumor growth curves (means ± SE) of vehicle, anti–PD-L1 antibody alone (300 μg per body, once weekly), ceralasertib alone (50 mg/kg, 5 of 7 days, once a day.), and ceralasertib plus anti–PD-L1 antibody groups in B6129F1 mice injected with RPP cells ( n = 4 in vehicle and anti–PD-L1 antibody group, n = 6 in the other groups). ( B to E ) RPP tumors were harvested on day 22 for immune profiling by flow cytometry ( n = 4 in vehicle and anti–PD-L1 antibody group, n = 6 in ceralasertib, n = 5 in ceralasertib plus anti–PD-L1 antibody group). Flow cytometry analysis of (B) CD45 + CD3 + T cells, (C) CD45 + CD3 + CD8 + T cells, (D) CD45 + CD3 + CD8 + ICOS + T cells, (E) effector memory CD8 + T cells: CD45 + CD3 + CD8 + CD44 hi CD62L lo . Percentages in (B), (C), and (E) were calculated relative to CD45 + cells, and percentages in (D) were calculated relative to CD45 + CD8 + cells. ( F ) CD8 immunohistochemistry was performed on tumor sections resected on day 22. Scale bar, 50 μm. ( G ) Tumor growth curves (means ± SE) of vehicle, anti–PD-L1 antibody alone, ceralasertib alone, and ceralasertib plus anti–PD-L1 antibody [same dose as (A)] groups in B6FVBF1/J mice injected with RPM cells ( n = 6 per group). ( H to K ) RPM tumors were harvested at day 18 for immune profiling by flow cytometry ( n = 5 in anti–PD-L1 group and n = 6 in the other groups). Flow cytometry analysis of (H) CD45 + CD3 + T cells, (I) CD45 + CD3 + CD8 + T cells, (J) CD45 + CD3 + CD8 + ICOS + T cells, and (K) effector memory CD8 + T cells: CD45 + CD3 + CD8 + CD44 hi CD62L lo . Percentages were the ratio to CD45 + cells. ( L ) CD8 immunohistochemistry of tumors resected on day 18. Scale bar, 50 μm. Cerala, ceralasertib. P values were calculated by one-way analysis of variance (ANOVA). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, and by Student’s t test for comparing ceralasertib alone and ceralasertib plus anti–PD-L1 antibody (A). ab, antibody. ns, not significant.

    Article Snippet: Paraffin blocks were sectioned at 5-μm thickness, and immunohistochemistry was performed with anti-CD8a antibody [Cedarlane, HS-3610003(Sy)].

    Techniques: Injection, Flow Cytometry, Immunohistochemistry

    FACS-Analysis of spleen DX5 + NKT cells revealed interstrain differences in several phenotypical markers between NK1.1 - Balb/c and NK1.1 + C57Bl/6 mice . In the NK1.1 + mice strain spleen DX5 + NKT cells expressed less CD4 but more CD8 (A). Upon activation the TCR α/β down-regulation was confirmed. In addition to NK.1.1 more spleen DX5 + NKT cells in C57Bl/6 mice were positive for CD94 (B). Maturation marker CD62L was slightly higher expressed in freshly-isolated spleen DX5 + NKT cells in C57Bl/6 mice compared to Balb/c, whereas CD103 was less (C). Functional marker CD154 and CD178 were only little expressed in freshly-isolated spleen DX5 + NKT cells in both mice strains (D). Upon stimulation spleen DX5 + NKT cells in NK1.1 + C57Bl/6 mice displayed less up-regulation of CD154 compared to Balb/c. Results are given as mean + SEM. Experiments were repeated at least three times (* p < 0.05).

    Journal: BMC Immunology

    Article Title: DX5 + NKT cells display phenotypical and functional differences between spleen and liver as well as NK1.1 - Balb/c and NK1.1 + C57Bl/6 mice

    doi: 10.1186/1471-2172-12-26

    Figure Lengend Snippet: FACS-Analysis of spleen DX5 + NKT cells revealed interstrain differences in several phenotypical markers between NK1.1 - Balb/c and NK1.1 + C57Bl/6 mice . In the NK1.1 + mice strain spleen DX5 + NKT cells expressed less CD4 but more CD8 (A). Upon activation the TCR α/β down-regulation was confirmed. In addition to NK.1.1 more spleen DX5 + NKT cells in C57Bl/6 mice were positive for CD94 (B). Maturation marker CD62L was slightly higher expressed in freshly-isolated spleen DX5 + NKT cells in C57Bl/6 mice compared to Balb/c, whereas CD103 was less (C). Functional marker CD154 and CD178 were only little expressed in freshly-isolated spleen DX5 + NKT cells in both mice strains (D). Upon stimulation spleen DX5 + NKT cells in NK1.1 + C57Bl/6 mice displayed less up-regulation of CD154 compared to Balb/c. Results are given as mean + SEM. Experiments were repeated at least three times (* p < 0.05).

    Article Snippet: The following reagents were used for cell surface labeling in multiparameter flow cytometric analysis (FACS Calibur, BD Bioscience): FITC or Alexa Fluoar 647-conjugated anti-mouse CD3 (clone: 17A2, rat IgG2b), APC-conjugated anti-mouse-CD4 (clone: GK1.5, rat IgG2b), APC-conjugated anti-mouse-CD8a (clone: 53-6.7, rat IgG2a), PE-conjugated anti-mouse-CD38 (clone: 90, rat IgG2a), PE-conjugated anti-mouse-CD49b (clone: DX5, rat IgM), APC-conjugated anti-mouse-CD62L (clone: MEL-14, rat IgG2a), PE-conjugated anti-mouse-CD103 (clone: M290, rat IgG2a), PE-conjugated anti-mouse-CD178 (Fas-Ligand) (clone: MFL3, hamster IgG1), PE-conjugated anti-mouse-Vβ 8.1, 8.2 TCR (clone: MR5-2, rat IgG2a) all BD Biosciences.

    Techniques: Activation Assay, Marker, Isolation, Functional Assay

    C57BL/6 mice were infected with P. berghei ANKA and treated with vehicle, losartan or captopril by gavage. T cells were isolated at day 6 post infection, stained with fluorescent antibodies, and analyzed by flow cytometry. (A) Representative dot plots of CD4 + CD69 + and CD8 + CD69 + T cells obtained from gated CD3 + cells. Percentage of CD4 + CD69 + T cells (B) and CD8 + CD69 + T cells (C). Parasitemia was determined by Giemsa-stained blood smears in vehicle- (solid line), losartan- (dotted line) or captopril- (dash line) treated mice (D). Mortality was checked daily in vehicle- (▪), losartan- (▴) or captopril- (▾) treated mice (E). Behavioral analysis was assessed as described in Materials and Methods (F). Evans blue dye extraction from the brain tissue to evaluate blood-brain barrier disruption (G). The results are expressed as means±SD. Statistically significant compared with values for *naive mice ( p <0.05) and #vehicle-treated mice infected with P. berghei ANKA ( p <0.05). Statistically significant compared with values for vehicle-treated infected mice at a day 5, b day 7 or day c 10 post-infection.

    Journal: PLoS ONE

    Article Title: Angiotensin II Is a New Component Involved in Splenic T Lymphocyte Responses during Plasmodium berghei ANKA Infection

    doi: 10.1371/journal.pone.0062999

    Figure Lengend Snippet: C57BL/6 mice were infected with P. berghei ANKA and treated with vehicle, losartan or captopril by gavage. T cells were isolated at day 6 post infection, stained with fluorescent antibodies, and analyzed by flow cytometry. (A) Representative dot plots of CD4 + CD69 + and CD8 + CD69 + T cells obtained from gated CD3 + cells. Percentage of CD4 + CD69 + T cells (B) and CD8 + CD69 + T cells (C). Parasitemia was determined by Giemsa-stained blood smears in vehicle- (solid line), losartan- (dotted line) or captopril- (dash line) treated mice (D). Mortality was checked daily in vehicle- (▪), losartan- (▴) or captopril- (▾) treated mice (E). Behavioral analysis was assessed as described in Materials and Methods (F). Evans blue dye extraction from the brain tissue to evaluate blood-brain barrier disruption (G). The results are expressed as means±SD. Statistically significant compared with values for *naive mice ( p <0.05) and #vehicle-treated mice infected with P. berghei ANKA ( p <0.05). Statistically significant compared with values for vehicle-treated infected mice at a day 5, b day 7 or day c 10 post-infection.

    Article Snippet: Fluorescein isothiocyanate (FITC)-, phycoerythrin (PE)- and PE-Cy5.5-conjugated hamster IgG1 anti-murine CD3 (145-2C11), PE- and PerCP-conjugated rat IgG2a anti-murine CD4 (RM4-5), PE-conjugated rat IgG2a anti-murine CD8a (53–6.7), FITC-conjugated rat IgG2a anti-murine CD45R/B220 (RA3-6B2), PE-Cy5-conjugated rat IgG2b anti-murine CD44 (IM7), FITC-conjugated rat IgG2a anti-murine CD62L (MEL-14), PE-conjugated rat IgG1 anti-murine IFN-γ (XMG1.2), PE-conjugated rat IgG1 anti-murine IL-17 (TC11-18H10), PE-conjugated rat IgG2b anti-murine IL-10 (JES5-16E3), PE-conjugated rat IgG2b anti-murine IL-4 (BVD4-1D11), biotin-conjugated rat IgG2a anti-murine CD11a (MD17/4), PE-conjugated streptavidin, PerCP/PE/FITC-conjugated hamster IgG1 and IgG2, and goat IgG2a isotype controls were all purchased from BD Pharmingen (San Diego, CA, USA).

    Techniques: Infection, Isolation, Staining, Flow Cytometry

    T cells from naive mice and mice infected with P. berghei ANKA treated with vehicle, losartan or captopril by gavage were isolated at day 6 post infection, stained with fluorescent antibodies and analyzed by flow cytometry. (A) Representative dot plots of perforin + CD8 + T cells obtained from gated CD3 + cells. The percentage (B) and absolute number ( C ) of perforin + CD8 + T cells were determined. The results are expressed as means±SD. Statistically significant compared with values for *naive mice ( p <0.05) and #vehicle-treated mice infected with P. berghei ANKA ( p <0.05).

    Journal: PLoS ONE

    Article Title: Angiotensin II Is a New Component Involved in Splenic T Lymphocyte Responses during Plasmodium berghei ANKA Infection

    doi: 10.1371/journal.pone.0062999

    Figure Lengend Snippet: T cells from naive mice and mice infected with P. berghei ANKA treated with vehicle, losartan or captopril by gavage were isolated at day 6 post infection, stained with fluorescent antibodies and analyzed by flow cytometry. (A) Representative dot plots of perforin + CD8 + T cells obtained from gated CD3 + cells. The percentage (B) and absolute number ( C ) of perforin + CD8 + T cells were determined. The results are expressed as means±SD. Statistically significant compared with values for *naive mice ( p <0.05) and #vehicle-treated mice infected with P. berghei ANKA ( p <0.05).

    Article Snippet: Fluorescein isothiocyanate (FITC)-, phycoerythrin (PE)- and PE-Cy5.5-conjugated hamster IgG1 anti-murine CD3 (145-2C11), PE- and PerCP-conjugated rat IgG2a anti-murine CD4 (RM4-5), PE-conjugated rat IgG2a anti-murine CD8a (53–6.7), FITC-conjugated rat IgG2a anti-murine CD45R/B220 (RA3-6B2), PE-Cy5-conjugated rat IgG2b anti-murine CD44 (IM7), FITC-conjugated rat IgG2a anti-murine CD62L (MEL-14), PE-conjugated rat IgG1 anti-murine IFN-γ (XMG1.2), PE-conjugated rat IgG1 anti-murine IL-17 (TC11-18H10), PE-conjugated rat IgG2b anti-murine IL-10 (JES5-16E3), PE-conjugated rat IgG2b anti-murine IL-4 (BVD4-1D11), biotin-conjugated rat IgG2a anti-murine CD11a (MD17/4), PE-conjugated streptavidin, PerCP/PE/FITC-conjugated hamster IgG1 and IgG2, and goat IgG2a isotype controls were all purchased from BD Pharmingen (San Diego, CA, USA).

    Techniques: Infection, Isolation, Staining, Flow Cytometry

    Flow cytometry analysis of the spleen CD3 + DX5 + NKT, CD8 + T, CD4 + CD62L high , and CD4 + CD62L low cells of Balb/c mice after separation by MACS and FACS sorting (a). Proliferation (b) and proliferation index (c) of CFSE-labeled CD4 + CD62L high cells after 48 h and 96 h of monoculture or coculture with CD8 + T cells or CD3 + DX5 + NKT. Results are given as mean + SEM. Experiments were repeated at least three times ( ∗ P < 0.05).

    Journal: Journal of Immunology Research

    Article Title: Murine DX5 + NKT Cells Display Their Cytotoxic and Proapoptotic Potentials against Colitis-Inducing CD4 + CD62L high T Cells through Fas Ligand

    doi: 10.1155/2018/8175810

    Figure Lengend Snippet: Flow cytometry analysis of the spleen CD3 + DX5 + NKT, CD8 + T, CD4 + CD62L high , and CD4 + CD62L low cells of Balb/c mice after separation by MACS and FACS sorting (a). Proliferation (b) and proliferation index (c) of CFSE-labeled CD4 + CD62L high cells after 48 h and 96 h of monoculture or coculture with CD8 + T cells or CD3 + DX5 + NKT. Results are given as mean + SEM. Experiments were repeated at least three times ( ∗ P < 0.05).

    Article Snippet: The following reagents were used for cell labeling in multiparameter flow cytometric analysis (FACS Calibur, BD Biosciences): PE or FITC-conjugated anti-mouse CD4 (clone: RM4-5, Rat IgG2b) Alexa 648 or FITC-conjugated anti-mouse CD3 (clone: 17A2, rat IgG2b), Alexa 648 or FITC-conjugated anti-mouse-CD8a (clone: 53–6.7, rat IgG2a), PE-conjugated anti-mouse-CD49b (clone: DX5, rat IgM), FITC- or PE-conjugated anti-mouse-CD62L (clone: MEL-14, rat IgG2a), and FITC- or PE-conjugated anti-mouse-CD178 (Fas ligand) (clone: MFL3, hamster IgG1); all are from BD Biosciences.

    Techniques: Flow Cytometry, Labeling

    Intracellular flow cytometry detection of IFN- γ in CD4 + CD62L high (a) and CD4 + CD62L low cells (b) after 4 h and 10 h of monoculture or coculture with CD8 + T cells or CD3 + DX5 + NKT. Results are given as mean + SEM. Experiments were repeated at least three times ( ∗ P < 0.05).

    Journal: Journal of Immunology Research

    Article Title: Murine DX5 + NKT Cells Display Their Cytotoxic and Proapoptotic Potentials against Colitis-Inducing CD4 + CD62L high T Cells through Fas Ligand

    doi: 10.1155/2018/8175810

    Figure Lengend Snippet: Intracellular flow cytometry detection of IFN- γ in CD4 + CD62L high (a) and CD4 + CD62L low cells (b) after 4 h and 10 h of monoculture or coculture with CD8 + T cells or CD3 + DX5 + NKT. Results are given as mean + SEM. Experiments were repeated at least three times ( ∗ P < 0.05).

    Article Snippet: The following reagents were used for cell labeling in multiparameter flow cytometric analysis (FACS Calibur, BD Biosciences): PE or FITC-conjugated anti-mouse CD4 (clone: RM4-5, Rat IgG2b) Alexa 648 or FITC-conjugated anti-mouse CD3 (clone: 17A2, rat IgG2b), Alexa 648 or FITC-conjugated anti-mouse-CD8a (clone: 53–6.7, rat IgG2a), PE-conjugated anti-mouse-CD49b (clone: DX5, rat IgM), FITC- or PE-conjugated anti-mouse-CD62L (clone: MEL-14, rat IgG2a), and FITC- or PE-conjugated anti-mouse-CD178 (Fas ligand) (clone: MFL3, hamster IgG1); all are from BD Biosciences.

    Techniques: Flow Cytometry

    Intracellular flow cytometry analysis of caspase-3 in CD4 + CD62L high cells after 10 h and 48 h of monoculture or coculture with CD8 + T or CD3 + DX5 + NKT cells. Results are given as mean + SEM. Experiments were repeated at least three times ( ∗ P < 0.05).

    Journal: Journal of Immunology Research

    Article Title: Murine DX5 + NKT Cells Display Their Cytotoxic and Proapoptotic Potentials against Colitis-Inducing CD4 + CD62L high T Cells through Fas Ligand

    doi: 10.1155/2018/8175810

    Figure Lengend Snippet: Intracellular flow cytometry analysis of caspase-3 in CD4 + CD62L high cells after 10 h and 48 h of monoculture or coculture with CD8 + T or CD3 + DX5 + NKT cells. Results are given as mean + SEM. Experiments were repeated at least three times ( ∗ P < 0.05).

    Article Snippet: The following reagents were used for cell labeling in multiparameter flow cytometric analysis (FACS Calibur, BD Biosciences): PE or FITC-conjugated anti-mouse CD4 (clone: RM4-5, Rat IgG2b) Alexa 648 or FITC-conjugated anti-mouse CD3 (clone: 17A2, rat IgG2b), Alexa 648 or FITC-conjugated anti-mouse-CD8a (clone: 53–6.7, rat IgG2a), PE-conjugated anti-mouse-CD49b (clone: DX5, rat IgM), FITC- or PE-conjugated anti-mouse-CD62L (clone: MEL-14, rat IgG2a), and FITC- or PE-conjugated anti-mouse-CD178 (Fas ligand) (clone: MFL3, hamster IgG1); all are from BD Biosciences.

    Techniques: Flow Cytometry

    Flow cytometry analysis FasL expression of CD8 T and CD3 + DX5 + NKT cells after 4 h and 10 h monoculture or coculture with CD4 + CD62L high cells. Results are given as mean + SEM. Experiments were repeated at least three times ( ∗ P < 0.05).

    Journal: Journal of Immunology Research

    Article Title: Murine DX5 + NKT Cells Display Their Cytotoxic and Proapoptotic Potentials against Colitis-Inducing CD4 + CD62L high T Cells through Fas Ligand

    doi: 10.1155/2018/8175810

    Figure Lengend Snippet: Flow cytometry analysis FasL expression of CD8 T and CD3 + DX5 + NKT cells after 4 h and 10 h monoculture or coculture with CD4 + CD62L high cells. Results are given as mean + SEM. Experiments were repeated at least three times ( ∗ P < 0.05).

    Article Snippet: The following reagents were used for cell labeling in multiparameter flow cytometric analysis (FACS Calibur, BD Biosciences): PE or FITC-conjugated anti-mouse CD4 (clone: RM4-5, Rat IgG2b) Alexa 648 or FITC-conjugated anti-mouse CD3 (clone: 17A2, rat IgG2b), Alexa 648 or FITC-conjugated anti-mouse-CD8a (clone: 53–6.7, rat IgG2a), PE-conjugated anti-mouse-CD49b (clone: DX5, rat IgM), FITC- or PE-conjugated anti-mouse-CD62L (clone: MEL-14, rat IgG2a), and FITC- or PE-conjugated anti-mouse-CD178 (Fas ligand) (clone: MFL3, hamster IgG1); all are from BD Biosciences.

    Techniques: Flow Cytometry, Expressing